NHMRC Clinical Trials Centre, University of Sydney
ADA 2018
With support from the Australian Research Council and JDRF Australia, researchers at the University of Sydney have identified a set of microRNAs that can potentially assess the death of insulin-producing beta-cells in individuals with or progressing to Type 1 diabetes, monitor islet graft health, and assess efficacies of drugs aimed to retard beta-cell death. In collaboration with the RMIT University, they describe the development of point-of-care devices for Type 1 diabetes.
Social Media Lab at the APHA 2014 Meeting
APHA 2014